Lead identification of acetylcholinesterase inhibitors-histamine H3 receptor antagonists from molecular modeling (Q39324211)

11 September 2017

title

Lead identification of acetylcholinesterase inhibitors-histamine H3 receptor antagonists from molecular modeling (English)

1 reference

11 September 2017

Richard Apodaca

4

0 references

author name string

Scott D Bembenek

1

1 reference

11 September 2017

John M Keith

2

1 reference

11 September 2017

Michael A Letavic

3

1 reference

11 September 2017

Ann J Barbier

5

1 reference

11 September 2017

Lisa Dvorak

6

1 reference

11 September 2017

Leah Aluisio

7

1 reference

11 September 2017

Kirsten L Miller

8

1 reference

11 September 2017

Timothy W Lovenberg

9

1 reference

11 September 2017

Nicholas I Carruthers

10

1 reference

11 September 2017

language of work or name

English

0 references

publication date

25 December 2007

1 reference

Bioorganic & Medicinal Chemistry

11 September 2017

published in

1 reference

11 September 2017

volume

16

1 reference

11 September 2017

issue

6

1 reference

11 September 2017

page(s)

2968-2973

1 reference

A structural motif of acetylcholinesterase that promotes amyloid beta-peptide fibril formation

11 September 2017

cites work

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2007.12.048

Selective histamine H3 receptor antagonists for treatment of cognitive deficiencies and other disorders of the central nervous system

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2007.12.048

Memory assessment in studies of cognition-enhancing drugs for Alzheimer's disease

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2007.12.048

Structure of acetylcholinesterase complexed with the nootropic alkaloid, (-)-huperzine A

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2007.12.048

Is polarization important in cation-π interactions?

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2007.12.048

Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2007.12.048

Three-dimensional models of histamine H3 receptor antagonist complexes and their pharmacophore

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2007.12.048

Designed multiple ligands. An emerging drug discovery paradigm

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2007.12.048

Acetylcholinesterase: molecular modeling with the whole toolkit

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2007.12.048

Properties of water molecules in the active site gorge of acetylcholinesterase from computer simulation

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2007.12.048

Cation-pi interactions in structural biology

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2007.12.048

Inhibition of cortical acetylcholine release and cognitive performance by histamine H3 receptor activation in rats

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2007.12.048

Active-site gorge and buried water molecules in crystal structures of acetylcholinesterase from Torpedo californica 1 1Edited by R. Huber

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2007.12.048

Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2007.12.048

Conformation gating as a mechanism for enzyme specificity

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2007.12.048

The safety and tolerability of donepezil in patients with Alzheimer's disease

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2007.12.048

Role of the catalytic triad and oxyanion hole in acetylcholinesterase catalysis: an ab initio QM/MM study

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2007.12.048

A new class of diamine-based human histamine H3 receptor antagonists: 4-(aminoalkoxy)benzylamines

1 August 2024

2 references

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2007.12.048

1 August 2024

https://opencitations.net/index/api/v1/citations/10.1021/JM030185V

The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2007.12.048

Perspectives on cognitive domains, H3 receptor ligands and neurological disease

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2007.12.048

Cholinesterase inhibitors stabilize Alzheimer disease

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2007.12.048

Design and synthesis of dual inhibitors of acetylcholinesterase and serotonin transporter targeting potential agents for Alzheimer's disease.

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2007.12.048

Combination therapy in Alzheimer's disease: a review of current evidence

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2007.12.048

Structure of acetylcholinesterase complexed with (-)-galanthamine at 2.3 A resolution

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2007.12.048

Long-term cholinesterase inhibitor treatment of Alzheimer's disease.

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2007.12.048

Structure and energetics of ligand binding to proteins: Escherichia coli dihydrofolate reductase-trimethoprim, a drug-receptor system.

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2007.12.048

Kinetic and structural studies on the interaction of cholinesterases with the anti-Alzheimer drug rivastigmine

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2007.12.048

Atomic Structure of Acetylcholinesterase from Torpedo californica : A Prototypic Acetylcholine-Binding Protein

1 August 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BMC.2007.12.048

10.1016/J.BMC.2007.12.048

1 August 2024

Identifiers

DOI

1 reference

11 September 2017

1 reference